Senior Director, New Product Strategy & Planning, North America

Ipsen•Cambridge, MA

About The Position

The New Product Strategy and Planning, North America role is part of the Business Operations & Strategy team and reports directly into the VP of Business Operations. This role is responsible for partnering with the Global New Product Strategy & Innovation Team, the business development team, and North America leadership to provide a commercial perspective for the US market to the ongoing assessment of external assets and opportunities. In addition, this person will partner with the global team to establish and implement early commercialization and pre-launch plans that are fit for US market to maximize asset value. To support this vision, the Senior Director, New Product Strategy & Planning, North America role will be responsible for: Contribution to the evolution of the Therapeutic Area & Franchise Strategies US market opportunity assessment for external asset evaluations in strong collaboration with the Global Partnering & Global New Product Strategy teams Develop a vision for the new product planning function for North America, focused on transition of internal assets (including early commercial phase 1-2 assets and pre-launch Ph 3 assets) from global to US brand team Support External Innovation / New Product / Portfolio Strategy: Provide US perspective for external innovation strategies across therapeutic areas, including access & pricing Apply the therapeutic area strategies to the determination of external innovation and business development priorities with a focus on the US market Partner with key functions, including Value & Access, to develop US Market opportunity assessment to identify asset potential, fit with strategy, and identify potential risks Identify and implement opportunities to enhance the business development assessment process Be the US commercial lead across all stages of the business development & external innovation Work with Global Partnering & External Innovation to seek out new opportunities proactively as well as providing detailed feedback on assets in triage Partner with Global New Product strategy to lead in-depth commercial evaluation process for NA (e.g., current & future landscaping, secondary and primary market research, forecasting, pricing & access assessment, SMM estimation, etc.) to inform commercial evaluation and diligence Be a proactive partner and work collaboratively with cross-functional teams (e.g., business development, external innovation, medical affairs, R&D, regulatory, finance, countries, global pricing & access, business excellence) to support inputs required for commercial modelling & business case development Ensure streamlined, efficient, and quality content generation across all evaluations aligning with internal processes Own & present NA opportunity assessment for external assets to cross-functional team and executive leadership teams Work closely with other counterparts across franchises to share best practices and business opportunities Driving Internal Pipeline Value & Operationalization for NA Assess process and develop perspective for better integration of new assets across phases 1 – 3 into Ipsen pipeline and NA teams Provide US perspective into launch planning considerations to earlier phase development, including consideration of US value and access and other commercialization critical success factors Continued focus on New Product Strategy & Innovation Team Development & Performance Support the VP, Business Operations & Strategy and NA President in identifying best opportunities for US Driving Internal Pipeline Value & Operationalization for NA Assess process and develop perspective for better integration of new assets across phases 1 – 3 into Ipsen pipeline and NA teams Provide US perspective into launch planning considerations to earlier phase development, including consideration of US value and access and other commercialization critical success factors Continued focus on New Product Strategy & Innovation Team Development & Performance Support the VP, Business Operations & Strategy and NA President in identifying best opportunities for US

Requirements

A minimum of 7 - 10 years’ experience in New Product Planning, Global Marketing, Business Development or Portfolio Management roles within the biopharmaceutical industry, including experience in early commercial planning, disease area strategy, business development activity, and forecasting
Strong scientific, medical, and commercial experience in oncology, neuroscience and/or rare diseases with a proven knowledge of clinical pipeline planning, business development, and launch activities
Experience developing cross-functional pre-commercialization plans within pharmaceutical company or management consulting
Experience in working across a cross-functional matrix team to meet deliverables on time and budget
Competitive landscaping experience
Strategic marketing expertise (including positioning, targeting, segmentation, launch planning, life cycle management) is highly preferred
Strong business acumen and understanding of US market
Excellent analytical skills and strategic thinking, including forecasting and business case development
Strong communication and presentation skills
Sense of urgency and experience in delivering parallel workstreams efficiently
Qualitative & quantitative market research experience
Strong planning and project management skills
Advanced degree in Life Sciences-related discipline and/or an MBA
Fluent in English

Nice To Haves

Strategy consulting experience in life sciences (including work in early-commercial strategy, commercialization, LCM, BD, due diligence, etc.) is highly valued
Experience in pricing and access in the US market is preferred
Strategic marketing expertise (including positioning, targeting, segmentation, launch planning, life cycle management) is highly preferred
Knowledge of additional languages such as French would be helpful.

Responsibilities

Contribution to the evolution of the Therapeutic Area & Franchise Strategies
US market opportunity assessment for external asset evaluations in strong collaboration with the Global Partnering & Global New Product Strategy teams
Develop a vision for the new product planning function for North America, focused on transition of internal assets (including early commercial phase 1-2 assets and pre-launch Ph 3 assets) from global to US brand team
Support External Innovation / New Product / Portfolio Strategy: Provide US perspective for external innovation strategies across therapeutic areas, including access & pricing
Apply the therapeutic area strategies to the determination of external innovation and business development priorities with a focus on the US market
Partner with key functions, including Value & Access, to develop US Market opportunity assessment to identify asset potential, fit with strategy, and identify potential risks
Identify and implement opportunities to enhance the business development assessment process
Be the US commercial lead across all stages of the business development & external innovation
Work with Global Partnering & External Innovation to seek out new opportunities proactively as well as providing detailed feedback on assets in triage
Partner with Global New Product strategy to lead in-depth commercial evaluation process for NA (e.g., current & future landscaping, secondary and primary market research, forecasting, pricing & access assessment, SMM estimation, etc.) to inform commercial evaluation and diligence
Be a proactive partner and work collaboratively with cross-functional teams (e.g., business development, external innovation, medical affairs, R&D, regulatory, finance, countries, global pricing & access, business excellence) to support inputs required for commercial modelling & business case development
Ensure streamlined, efficient, and quality content generation across all evaluations aligning with internal processes
Own & present NA opportunity assessment for external assets to cross-functional team and executive leadership teams
Work closely with other counterparts across franchises to share best practices and business opportunities
Driving Internal Pipeline Value & Operationalization for NA
Assess process and develop perspective for better integration of new assets across phases 1 – 3 into Ipsen pipeline and NA teams
Provide US perspective into launch planning considerations to earlier phase development, including consideration of US value and access and other commercialization critical success factors
Continued focus on New Product Strategy & Innovation Team Development & Performance
Support the VP, Business Operations & Strategy and NA President in identifying best opportunities for US
Driving Internal Pipeline Value & Operationalization for NA
Assess process and develop perspective for better integration of new assets across phases 1 – 3 into Ipsen pipeline and NA teams
Provide US perspective into launch planning considerations to earlier phase development, including consideration of US value and access and other commercialization critical success factors
Continued focus on New Product Strategy & Innovation Team Development & Performance
Support the VP, Business Operations & Strategy and NA President in identifying best opportunities for US